Product
SHR-A2009
Aliases
SHR-A2009; SHR-1316
Name
SHR-A2009
4 clinical trials
4 indications
Indication
Breast CancerIndication
CancerIndication
Advanced Solid TumorIndication
NSCLCClinical trial
A Multi-center, Open-label Phase Ib/II Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast CancerStatus: Not yet recruiting, Estimated PCD: 2026-10-31
Clinical trial
A Phase I, Open-Label, Multicenter Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A2009 for Injection in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
An Open-label, Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A2009 for Injection in Patients With Advanced Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2025-06-01
Clinical trial
A Phase II Study of the Efficacy and Safety of SHR-A1921 or SHR-A2009 in Patients With Previously Treated Advanced NSCLCStatus: Not yet recruiting, Estimated PCD: 2026-06-01